Judit Riera‐Arnau

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

Sophie H. Bots, Judit Riera‐Arnau, Svetlana V. Belitser et al. · Frontiers in Pharmacology · 2022 · 28 citations · Full text

Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

Shahab Abtahi, Romin Pajouheshnia, Carlos E. Durán et al. · Drug Safety · 2023 · 24 citations · Full text